SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.42
+0.04 (+2.54%)
As of Nov 7, 2:06 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,041.3% upside
Low Target $10.52
Average Target $16.15
High Target $19.28
Current Price $1.42
Current
$1.42
Target
$16.15
$10.52 $16.15 avg $19.28
Scenario Analysis
Bear Case
$10.52
643.5%
Low target
Base Case
$16.15
+1,041.3%
Avg target
Bull Case
$19.28
+1,262.5%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.34
-39.5% from high
52-Week Low
$1.13
+25.2% from low
Target vs 52W High
$16.15
+590.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%